First Command Advisory Services’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$644K Buy
4,108
+3,041
+285% +$456K ﹤0.01% 112
2026
Q1
$163K Buy
1,067
+937
+721% +$144K ﹤0.01% 208
2025
Q4
$17.9K Buy
130
+30
+30% +$3.93K ﹤0.01% 426
2025
Q3
$12.8K Hold
100
﹤0.01% 414
2025
Q2
$12.1K Hold
100
﹤0.01% 393
2025
Q1
$11.1K Hold
100
﹤0.01% 375
2024
Q4
$9.73K Hold
100
﹤0.01% 387
2024
Q3
$11.5K Hold
100
﹤0.01% 372
2024
Q2
$10.6K Sell
100
-1
-1% -$100 ﹤0.01% 350
2024
Q1
$9.77K Buy
101
+1
+1% +$103 ﹤0.01% 364
2023
Q4
$10.1K Hold
100
﹤0.01% 349
2023
Q3
$10.2K Buy
+100
New +$10.2K ﹤0.01% 345
2023
Q2
Sell
-18
Closed 143
2023
Q1
$0 Buy
+18
New +$1.57K ﹤0.01% 199

Other funds holding NVS

First Command Advisory Services's NVS Position: Q2 2026 in Review

First Command Advisory Services increased its Novartis (NVS) stake by 285% in Q2 2026, buying an estimated $456K and bringing the position to 4,108 shares worth $644K. The position accounts for ﹤0.01% of the portfolio, ranked #112.

First Command Advisory Services first reported a position in NVS in Q1 2023 and has held it in 13 quarters since. 1,619 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • First Command Advisory Services held 4,108 shares of Novartis worth $644K as of Q2 2026.
  • First Command Advisory Services bought 3,041 Novartis shares in Q2 2026, an estimated $456K.
  • Novartis made up ﹤0.01% of First Command Advisory Services's portfolio in Q2 2026, its #112 holding.
  • First Command Advisory Services first reported a position in Novartis in Q1 2023 and has held it in 13 quarters since.
  • 1,619 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on First Command Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.